Patents by Inventor Anne Zimmermann

Anne Zimmermann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Nilotinib Compositions with Enhanced Solubility
    Publication number: 20210260058
    Abstract: Described are compositions and methods of a salt of Nilotinib and a polymer that has improved properties in terms of solubility and bioavailability, which are useful for treating disorders of uncontrolled cellular proliferation.
    Type: Application
    Filed: February 18, 2021
    Publication date: August 26, 2021
    Inventors: Stephen R. Byrn, Dan Smith, Anne Zimmermann, Bjarke Strøm Larsen, Fang Tian
  • Hydrobromide salt of pridopidine
    Patent number: 9814706
    Abstract: This invention relates to a new salt of Pridopidine, a drug substance currently in development for the treatment of Huntington's disease. More specifically the invention provides the pharmaceutically acceptable hydrobromide salt, pharmaceutical compositions comprising this salt, and uses of this salt as a drug substance.
    Type: Grant
    Filed: February 4, 2015
    Date of Patent: November 14, 2017
    Assignee: TEVA PHARMACEUTICALS INTERNATIONAL GMBH
    Inventors: Anne Zimmermann, Brian Frøstrup
  • HYDROBROMIDE SALT OF PRIDOPIDINE
    Publication number: 20150209344
    Abstract: This invention relates to a new salt of Pridopidine, a drug substance currently in development for the treatment of Huntington's disease. More specifically the invention provides the pharmaceutically acceptable hydrobromide salt, pharmaceutical compositions comprising this salt, and uses of this salt as a drug substance.
    Type: Application
    Filed: February 4, 2015
    Publication date: July 30, 2015
    Applicant: IVAX INTERNATIONAL GMBH
    Inventors: Anne ZIMMERMANN, Brian FRØSTRUP
  • Hydrobromide salt of pridopidine
    Patent number: 9012476
    Abstract: This invention relates to a new salt of Pridopidine, a drug substance currently in development for the treatment of Huntington's disease. More specifically the invention provides the pharmaceutically acceptable hydrobromide salt, pharmaceutical compositions comprising this salt, and uses of this salt as a drug substance.
    Type: Grant
    Filed: December 7, 2012
    Date of Patent: April 21, 2015
    Assignee: Ivax International GmbH
    Inventors: Anne Zimmermann, Brian Frøstrup
  • Polymorphic form of pridopidine hydrochloride
    Patent number: 9006445
    Abstract: This invention relates to a new crystalline form of Pridopidine, a drug substance currently in development for the treatment of Huntington's disease. More specifically the invention provides polymorphic Form II of the Pridopidine hydrochloride salt, a process for the preparation of this polymorphic form, pharmaceutical compositions comprising polymorphic Form II, and methods of uses of this polymorphic form.
    Type: Grant
    Filed: September 6, 2012
    Date of Patent: April 14, 2015
    Assignee: Ivax International GmbH
    Inventors: Clas Sonesson, Thomas Pittelkow, Brian Frøstrup, Anne Zimmermann
  • POLYMORPHIC FORM OF PRIDOPIDINE HYDROCHLORIDE
    Publication number: 20140315951
    Abstract: This invention relates to a new crystalline form of Pridopidine, a drug substance currently in development for the treatment of Huntington's disease. More specifically the invention provides polymorphic Form II of the Pridopidine hydrochloride salt, a process for the preparation of this polymorphic form, pharmaceutical compositions comprising polymorphic Form II, and methods of uses of this polymorphic form.
    Type: Application
    Filed: September 6, 2012
    Publication date: October 23, 2014
    Applicant: IVAX INTERNATIONAL GMBH
    Inventors: Clas Sonesson, Thomas Pittelkow, Brian Frøstrup, Anne Zimmermann